Jonathanm Barratt News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Jonathanm Barratt. Real-time updates on events, politics, business and more.

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet (1)

August 15, 2023

STOCKHOLM, Aug. 15, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX)...

United States United Kingdom Jonathanm Barratt United States Federal Drug Administration European Union Member States University Of Leicester

Source: europapress.es

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet

August 15, 2023

/PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced publication in The Lancet of the full data...

United Kingdom United States Jonathanm Barratt European Commission Exchange Commission United States Federal Drug Administration

Source: prnewswire.com

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet (2)

August 15, 2023

STOCKHOLM, Aug. 15, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX)...

United Kingdom United States Jonathanm Barratt University Of Leicester European Union Member States United States Federal Drug Administration

Source: europapress.es

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Jonathanm Barratt News Today

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet (1)

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet (2)

Explore More Categories